Virtue® Male Sling Fixation Study

Stopped early

Conditions studied: Stress Urinary Incontinence

In brief

This study is a multi-center study that will assess the efficacy and safety of suture fixation of the Virtue® Male Sling.

Key facts

Study ID

NCT01170728

Run by

Coloplast A/S

People needed

44

Starts

2010-07-01

Expected to finish

2014-06-01

Last updated by the study team

2015-08-24

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Male subject at least 18 years of age with an estimated life expectancy of of more than 5 years
• The subject has confirmed stress urinary incontinence (SUI) through medical history , urodynamics, and/or physical exam for at least 6 months
• The subject has completed post-void residual per protocol within 6 weeks prior to implant
• The subject has completed cystoscopy as per protocol within 12 months prior to implant
• The subject has intrinsic sphincter deficiency due to one of the following: post-transurethral resection of the prostate (TURP), simple open prostatectomy, or radical prostatectomy completed at least 6 months prior to implantation date
• The subject has failed at least two non-invasive therapies, eg. pelvic/Kegel exercises, behavioral modification or biofeedback for at least 6 months
• The subject is willing to have the Virtue® Male Sling implanted
• The subject is able and willing to complete all follow-up visits and procedures indicated in the protocol
• The subject has been informed of the nature of the study and agrees to its provisions and has provided written informed consent as approved by the local ethics committee of the respective site

You may not qualify if…

• The subject is unable or unwilling to sign the informed consent form (ICF)and/or comply with all follow-up requirements according to the study protocol
• The subject has an active urinary tract infection or active skin infection in region of surgery
• The subject has serious bleeding disorders
• The subject has incontinence due to neurogenic causes defined as multiple sclerosis, spinal cord/brain injury, cerebrovascular accident (CVA), detrusor-external sphincter dyssynergia, Parkinson's disease, or similar condition
• The subject had a previous implant to treat stress urinary incontinence
• The subject has undergone radiation, cryosurgery, or brachy therapy to treat prostate or other pelvic cancer within 6 months
• The subject is likely to undergo radiation therapy within the next 6 months
• The subject has active urethral or bladder neck stricture disease requiring continued treatment
• The subject has urge predominant incontinence
• The subject has an atonic bladder or a postvoid residual (PVR) greater than or equal to 150 milliliters (mL)
• The subject has a condition or disorder likely to require future transurethral procedure
• The subject is enrolled in a concurrent clinical study of any treatment (drug or device) that could affect continence function without sponsor's approval
• The subject is deemed unfit for male sling implantation or participation in a research protocol as determined by attending physician

Where it is running

• Mayo Clinic Arizona — Phoenix, Arizona, United States
• Kaiser Permanente — San Diego, California, United States
• Stanford University Medical Center — Stanford, California, United States
• Winter Park Urology — Orlando, Florida, United States
• Midtown Urology — Atlanta, Georgia, United States
• University of Chicago Medical Center — Chicago, Illinois, United States
• NYU Urology Associates — New York, New York, United States
• McKay Urology — Charlotte, North Carolina, United States
• Carolina Urologic Research Center — Myrtle Beach, South Carolina, United States
• Urology Associates of North Texas — Arlington, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.